General Archive
-
News releasesNew AI tool aims to detect early signs of dementia during routine eye tests
Data scientists and clinical researchers are working with high street opticians for the first time to develop a digital tool…
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
News releasesThird global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
News releasesLifeArc appoints Chief Medical Officer to deliver more scientific breakthroughs for patients
LifeArc has appointed healthcare leader and pharmaceutical industry expert, Dr Jonathan Morgan, as the charity’s first Chief Medical Officer. Jonathan…
-
News releases£2.7m infectious disease fund to boost rapid testing, drug trials and innovative specimen storage
Rapid diagnostic tests for deadly global viral threats, repurposing antibiotics to tackle neglected tropical diseases and a potential solution to…
-
News releasesLifeArc Ventures invests in Fluid Biomed
Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an…
-
News releasesPromising results in clinical trial gives hope to patients with blood disorder
A trial for a cutting-edge cell therapy that could become the first ever treatment for the rare, life-threatening blood disorder…
-
News releases3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Antimicrobial resistance (AMR) is one of the most urgent public health challenges of our time, threatening not only human health…
-
News releases
£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…
-
News releasesTackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
LifeArc has announced a significant £5 million investment to co-establish a new Centre for Translational AMR Research (CTAR) Programme at…
-
News releasesLifeArc joins public involvement pledge to improve health research
LifeArc has joined the Shared Commitment to Public Involvement, alongside more than 25 other leading health and research organisations such…
-
News releasesNewborn screening programme a big step forward for rare disease research
The announcement by Genomics England and NHS England on the newborn sequencing programme is a significant step forward in transforming…